In common with many companies operating in Nigeria, foreign exchange availability continues to impact our operations.
The challenge in accessing currency is affecting our ability to maintain consistent supply of medicines and vaccines in the market.
Sustainable patient access to our medicines and vaccines is a priority and we are doing all we can to limit the period of time the market will be out-of-stock on our products.
We recognise the current availability challenge is causing concern and we regret the disruption to patients and healthcare providers.
We are actively engaging with all our stakeholders to find a solution to enable sustainable supply of GSK medicines and vaccines to patients in Nigeria.
As always, we urge all patients to seek advice from their healthcare providers and ensure their medicines come from a trusted source.
Signed
Mr Omongiade Ehighebolo
Director of Communication and Government Affairs, GSK Consumer Nigeria Plc
